Computer platform helps match patients with cancer to trials of targeted therapy
As more patients with cancer have their tumors genomically profiled, and more therapies targeting genomic alterations enter clinical trials, the task of connecting patients to trials for which they are eligible can be especially challenging. A computer platform makes the matching process both easier and faster, its designers report in a new study.
Materials provided by Dana-Farber Cancer Institute. Note: Content may be edited for style and length.
Source link aaaaa
